Product Description: Allitinib tosylate (AST-1306 (TsOH)) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib tosylate also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib tosylate is an anilino-quinazoline compound and has anti-cancer activity[1]
Applications: Cancer-Kinase/protease
Formula: C31H26ClFN4O5S
References: [1]Xie H, Lin L, Tong L et al. AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivo. PLoS One. 2011;6(7):e21487.
CAS Number: 1050500-29-2
Molecular Weight: 621.08
Compound Purity: 99.83
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic)
Target: EGFR